BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22306670)

  • 1. Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutations.
    Nordgård O; Oltedal S; Janssen EA; Gilje B; Kørner H; Tjensvoll K; Smaaland R
    Diagn Mol Pathol; 2012 Mar; 21(1):9-13. PubMed ID: 22306670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
    Taback B; Bilchik AJ; Saha S; Nakayama T; Wiese DA; Turner RR; Kuo CT; Hoon DS
    Int J Cancer; 2004 Sep; 111(3):409-14. PubMed ID: 15221969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR.
    Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O
    Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fidelity DNA polymerase enhances the sensitivity of a peptide nucleic acid clamp PCR assay for K-ras mutations.
    Gilje B; Heikkilä R; Oltedal S; Tjensvoll K; Nordgård O
    J Mol Diagn; 2008 Jul; 10(4):325-31. PubMed ID: 18556764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe.
    Luo JD; Chan EC; Shih CL; Chen TL; Liang Y; Hwang TL; Chiou CC
    Nucleic Acids Res; 2006 Jan; 34(2):e12. PubMed ID: 16432256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
    Santiago FS; Todd AV; Hawkins NJ; Ward RL
    Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
    Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinoma.
    Messa F; Tonissi F; Millo E; Bracco E; Ungari S; Lattanzio L; Merlano M; Damonte G; Lo Nigro C
    Int J Biol Markers; 2014 Mar; 29(1):e55-61. PubMed ID: 24242294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coamplification at lower denaturation temperature polymerase chain reaction enables selective identification of K-Ras mutations in formalin-fixed, paraffin-embedded tumor tissues without tumor-cell enrichment.
    Yu S; Xie L; Hou Z; Qian X; Yu L; Wei J; Ding Y; Liu B
    Hum Pathol; 2011 Sep; 42(9):1312-8. PubMed ID: 21406308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased discordance of KRAS mutation detection in archived colorectal cancer specimens between the ARMS-Scorpion method and direct sequencing.
    Bando H; Tsuchihara K; Yoshino T; Kojima M; Ogasawara N; Fukushima H; Ochiai A; Ohtsu A; Esumi H
    Jpn J Clin Oncol; 2011 Feb; 41(2):239-44. PubMed ID: 21113056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.
    Fox JC; England J; White P; Ellison G; Callaghan K; Charlesworth NR; Hehir J; McCarthy TL; Smith-Ravin J; Talbot IC; Snary D; Northover JM; Newton CR; Little S
    Br J Cancer; 1998 Apr; 77(8):1267-74. PubMed ID: 9579832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-ras mutation detection in bladder cancer by COLD-PCR analysis and direct sequencing.
    Wang AX; Chang JW; Li CY; Liu K; Lin YL
    Urol Int; 2012; 88(3):350-7. PubMed ID: 22433386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
    Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.
    Lee S; Brophy VH; Cao J; Velez M; Hoeppner C; Soviero S; Lawrence HJ
    Virchows Arch; 2012 Feb; 460(2):141-9. PubMed ID: 22173329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.
    Araki T; Shimizu K; Nakamura K; Nakamura T; Mitani Y; Obayashi K; Fujita Y; Kakegawa S; Miyamae Y; Kaira K; Ishidao T; Lezhava A; Hayashizaki Y; Takeyoshi I; Yamamoto K
    J Mol Diagn; 2010 Jan; 12(1):118-24. PubMed ID: 20007840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
    Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
    Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors.
    Khanna M; Park P; Zirvi M; Cao W; Picon A; Day J; Paty P; Barany F
    Oncogene; 1999 Jan; 18(1):27-38. PubMed ID: 9926917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of K-ras mutations in colon cancer by PHA-PHFA (preferential homoduplex formation assay)].
    Funato T; Zeng Z; Satoh J; Fujiwara J; Kaku M; Sasaki T
    Rinsho Byori; 1999 Nov; 47(11):1059-63. PubMed ID: 10590684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.